substance p has been researched along with Parkinsonian Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, OY; de Souza Silva, MA; Nikolaus, S; Wang, AL | 1 |
| Ali, S; Chen, SH; Chu, CH; Hong, JS; Jiang, L; Kim, HC; Oyarzabal, E; Qian, L; Robinson, B; Wang, Q; Wilson, B | 1 |
| Jia, J; Li, B; Liu, L; Pan, Y; Sun, Z; Wang, H; Wang, X; Yu, F; Zhang, L | 1 |
| Betarbet, R; Greenamyre, JT | 1 |
| de Yébenes, JG; Fernández-Ruiz, J; González, S; Lastres-Becker, I; Mena, MA; Ramos, JA; Serrano, A | 1 |
| Fernandez-Barreiro, A; Fernandez-Villalba, E; Gomez-Gallego, M; Herrero, MT | 1 |
| Chen, L; Cui, QL; Yung, WH | 1 |
| Cheetham, S; Jenner, P; Lane, EL | 1 |
8 other study(ies) available for substance p and Parkinsonian Disorders
| Article | Year |
|---|---|
NK₃ receptor agonism reinstates temporal order memory in the hemiparkinsonian rat.
Topics: Animals; Male; Medial Forebrain Bundle; Memory; Movement; Neuropsychological Tests; Nootropic Agents; Oxidopamine; Parkinsonian Disorders; Peptide Fragments; Random Allocation; Rats, Wistar; Receptors, Neurokinin-3; Substance P; Time Perception | 2015 |
Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase.
Topics: Animals; Dopamine; Dopaminergic Neurons; Enzyme Activation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; NADPH Oxidases; Parkinsonian Disorders; Receptors, Neurokinin-1; Substance P | 2014 |
Electro-acupuncture stimulation improves motor disorders in Parkinsonian rats.
Topics: Animals; Antiparkinson Agents; Apomorphine; Brain; Disease Models, Animal; Dopamine; Dyskinesias; Electroacupuncture; Enkephalins; Glutamate Decarboxylase; Male; Medial Forebrain Bundle; Motor Activity; Neurons; Parkinsonian Disorders; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Substance P; Tyrosine 3-Monooxygenase | 2009 |
Regulation of dopamine receptor and neuropeptide expression in the basal ganglia of monkeys treated with MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Basal Ganglia; Disease Models, Animal; Dopamine; Down-Regulation; Enkephalins; Female; Functional Laterality; Globus Pallidus; Macaca mulatta; Neostriatum; Neuropeptides; Parkinsonian Disorders; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Substance P; Substantia Nigra; Up-Regulation | 2004 |
Cannabinoid CB(1) receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice.
Topics: Analysis of Variance; Animals; Basal Ganglia; Disease Models, Animal; Enkephalins; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Parkinsonian Disorders; Protein Precursors; Receptor, Cannabinoid, CB1; RNA, Messenger; Sex Factors; Statistics, Nonparametric; Substance P; Superoxide Dismutase; Tyrosine 3-Monooxygenase; Ubiquitin-Protein Ligases | 2005 |
Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholine; Animals; Biomarkers; Choline O-Acetyltransferase; Cholinergic Fibers; Disease Models, Animal; Down-Regulation; Electron Transport Complex IV; Female; In Situ Hybridization; Macaca fascicularis; Neurons; Neurotoxins; Parkinsonian Disorders; Pedunculopontine Tegmental Nucleus; Protein Subunits; RNA, Messenger; Substance P | 2007 |
Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats.
Topics: Action Potentials; Adrenergic Agents; Analysis of Variance; Animals; Behavior, Animal; Compulsive Behavior; Disease Models, Animal; Drug Interactions; Globus Pallidus; Male; Medial Forebrain Bundle; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Substance P; Tropanes | 2008 |
Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Behavior, Animal; Chlorobenzenes; Corpus Striatum; Cyclobutanes; Dynorphins; Enkephalins; Gene Expression; In Situ Hybridization; Levodopa; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; RNA, Messenger; Substance P; Time | 2008 |